Navigation Links
Mindray Medical Announces Top Management Change
Date:11/5/2012

SHENZHEN, China, Nov. 5, 2012 /PRNewswire-FirstCall/ ­‑‑ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that Mr. Xu Hang has resigned from his co-chief executive officer (co-CEO) position effective immediately, but will continue to serve as Mindray's chairman. Mr. Li Xiting, Mindray's president and co-CEO, has been appointed as CEO by the company's board of directors. He will continue to serve as president.

A key founding member of Mindray, Mr. Li has served as the company's director, president and co-CEO since 1991. He will continue to oversee Mindray's business operations and overall management. Mr. Li received his bachelor's degree from the University of Science and Technology of China.

"The board and I believe that separating the roles of chairman and CEO will strengthen the company's corporate governance, a necessary new structure to support Mindray's long-term prosperity," Mr. Xu commented. "I am very pleased that Mr. Li will continue to lead the company. I strongly believe that under his leadership, Mindray will execute its strategies successfully and be able to further accelerate its growth and expansion."

"Since Mindray's inception 21 years ago, Mr. Xu's outstanding vision and dedication have been instrumental to our success and to our transformation from a local Chinese medical device company to a publicly traded, internationally recognized corporation. We want to thank him for his significant contributions to the organization," Mr. Li commented. "I am very pleased that he will remain as our chairman and help our company make strategic decisions in the future. I am also much honored to be appointed as Mindray's president and CEO and look forward to continuing to lead the company to the next level."

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems. For more information, please visit http://ir.mindray.com.

For investor and media inquiries, please contact:

In the U.S:

Hoki Luk
Western Bridge, LLC
Tel: +1-646-808-9150
Email:     hoki.luk@westernbridgegroup.com

In China:

Cathy Gao
Mindray Medical International Limited
Tel: +86-755-8188-8023
Email:     cathy.gao@mindray.com


'/>"/>
SOURCE Mindray Medical International Limited
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Mindray Medical to Participate in MEDICA 2012 in Dusseldorf, Germany
2. Mindray Announces Second Quarter 2012 Financial Results
3. Mindray to Report Second Quarter 2012 Financial Results on August 6, 2012
4. Mindray Medical Completes Acquisition of Dragonbios Orthopedics Business
5. Mindray Medical to Present at AACC Clinical Lab Expo 2012
6. Mindray Announces First Quarter 2012 Financial Results
7. Mindray Medical to Acquire Controlling Stake in Hangzhou Optcla Medical Instrument
8. Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
9. Second Webinar in MedTech Trends Webcast Series on November 28, 2012; Navigating & Understanding the Sealing and Handling of Medical Microporous Materials
10. Dynamic Healthcare Services Acquires Evanko Respiratory Inc., a Provider of Medical Equipment and Respiratory Therapy Products and Services in Hazleton, PA
11. Varian Medical Systems Management to Present at Jefferies 2012 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Homozygous Familial Hypercholesterolemia (HoFH) - ... Global Markets Direct,s latest Pharmaceutical and Healthcare ... – Pipeline Review, H2 2016, provides an ... (Metabolic Disorders) pipeline landscape. Homozygous familial ... caused due to mutation from both parents. ...
(Date:12/6/2016)... The pen needles market is projected to reach USD ... 2016, growing at a CAGR of 11.2% during the ... years, the pen needles market has witnessed various technological ... for safety injections in the healthcare industry. These advancements ... with an aim to reduce pain, increase comfort, and ...
(Date:12/6/2016)... 2016   AlloSource , one of the ... and soft-tissue allografts for use in surgical procedures, ... for being named to the Board of Examiners ... by the Commerce Department,s National Institute of Standards ... process excellence. The Baldrige Award is the nation,s ...
Breaking Medicine Technology:
(Date:12/7/2016)... Arizona (PRWEB) , ... December 07, 2016 , ... Delete® ... Just in Time For The Holiday Party Season. Save Up To 33% Off Botox® ... Laser Salon is providing the Phoenix Valley with Delightful Deals on Botox® ...
(Date:12/7/2016)... ... , ... The medical profession is well aware that heart attacks do indeed ... heart attacks among 138,602 people recorded a 35% higher number of heart attacks in ... of course–no time of year is a good time for a heart attack! In ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... medicine device WellnessPro Plus for consumers and healthcare professionals to manage chronic ... by expanding the treatment modalities available in a single device. The announcement ...
(Date:12/7/2016)... ... 07, 2016 , ... “Tomorrow Trump Goes To Washington”: a brief but ... presidency and to America. “Tomorrow Trump Goes To Washington” is the creation of published ... for this country. , Nancy attributes her patriotic nature to her WWII veteran father. ...
(Date:12/7/2016)... ... (PRWEB) December 07, 2016 , ... ... individuals impacted by cerebral cavernous angiomas, was awarded a grant from the Julian ... engagement program. New Mexico has more people with cavernous angioma than anywhere in ...
Breaking Medicine News(10 mins):